🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-11
Trial ID
NCT00077116
Kidney transplantation is the best method of renal replacement in patients ...
Status
Completed
Location
University Hospital Ostrava
Start Date
2018-08-01
Trial ID
NCT06040684
Treatments Being Tested
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
This is a Phase 1 open-label, multicenter study of the safety and tolerabil...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2021-08-19
Trial ID
NCT04892043
Treatments Being Tested
Belatacept is an experimental medication shown in clinical trials to have i...
Status
Terminated
Location
University of California, San Francisco
Start Date
2006-12
Trial ID
NCT00346151
Treatments Being Tested
This is a 12-month phase 2, prospective, open label study to evaluate the e...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00446251
Treatments Being Tested
With this protocol the ALL-SCT BFM international study group wants * to ev...
Status
Unknown
Location
Universitätsklinik für Kinder- und Jugendheilkunde, Klin. Abt. f. Hämato-Onkologie
Start Date
2007-01
Trial ID
NCT01423500
RATIONALE: - Relapsed or refractory Neuroblastoma (NBL) carries a very poor...
Status
Withdrawn
Location
Children's Memorial Hospital
Start Date
2008-09
Trial ID
NCT00874315
This study is being done to test a transplant method that may have fewer si...
Status
Suspended
Location
St. Jude Children's Research Hospital
Start Date
2020-04-30
Trial ID
NCT04362293
This phase I/II trial studies the side effects of gene-modified immune cell...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-07-03
Trial ID
NCT03747484